The partnership has enabled Viralgen to scale up and complete a GMP trial material batch of Trogenix's therapy.

GEN talked with several contract development and manufacturing organizations (CDMOs) and/or contract research organizations (CROs) about new ways they are addressing AAV manufacturing challenges.

The Milan Cell and Gene Center of Excellence at AGC Biologics will produce LVV material for Treg cell therapy candidates.

With bipartisan momentum toward re-shoring essential health infrastructure, GeoVax stands ready to partner with HHS, BARDA, and other federal agencies to fulfill the Executive Order’s vision of a self ...

This strategic partnership marks a major milestone, encompassing the successful production of critical starting materials, including the establishment of Cell Banks and the manufacturing of Plasmids ...

In this interview with TheCable’s JANEFRANCES CHIBUNDU, Fadeyi speaks frankly on Nigeria’s proposed ban on solar panel ...

Hualong Biological 's research team has established a strong clinical foundation for its MATC platform through multiple investigator-initiated trials (IITs), demonstrating significant therapeutic ...

The fight against neglected tropical diseases is a fight for equity, productivity and long-term security. Southeast Asia can ...

May 2025 - eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, has entered into a strategic partnership with KU Leuven, one of Europe’s leading academic ...

Xmoor Pharma has entered into a strategic partnership with KU Leuven to support a new cell and gene therapy hub.